Location: New York, NY
CIK: 0001831942 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $1.679B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RLAY | RELAY THERAPEUTICS INC | 12,000,000 | $225M | 13.4% | — | — | COM | 75943R102 |
| ELVN | ENLIVEN THERAPEUTICS INC | 3,275,000 | $166M | 9.9% | — | — | COM | 29337E102 |
| ALKS | ALKERMES PLC | 3,000,000 | $157M | 9.4% | — | — | SHS | G01767105 |
| COGT | COGENT BIOSCIENCES INC | 3,050,000 | $118M | 7.0% | — | — | COM | 19240Q201 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 5,650,000 | $101M | 6.0% | — | — | COM | 03237H101 |
| DFTX | DEFINIUM THERAPEUTICS INC | 2,000,000 | $94.08M | 5.6% | — | — | COM SHS | 24477V105 |
| SYRE | SPYRE THERAPEUTICS INC | 846,786 | $75.18M | 4.5% | — | — | COM NEW | 00773J202 |
| ANRO | ALTO NEUROSCIENCE INC | 2,723,196 | $71.87M | 4.3% | — | — | COM SHS | 02157Q109 |
| TNGX | TANGO THERAPEUTICS INC | 2,250,000 | $70.33M | 4.2% | — | — | COM | 87583X109 |
| EYPT | EYEPOINT INC | 4,600,000 | $65.78M | 3.9% | — | — | COM NEW | 30233G209 |
| TYRA | TYRA BIOSCIENCES INC | 1,875,000 | $59.89M | 3.6% | — | — | COM | 90240B106 |
| GLTO | DAMORA THERAPEUTICS INC | 1,939,000 | $50.43M | 3.0% | — | — | COM NEW | 36322Q206 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 1,350,000 | $50.23M | 3.0% | — | — | COM NEW | 15117B202 |
| PHVS | PHARVARIS N V | 1,425,000 | $49.28M | 2.9% | — | — | COM | N69605108 |
| LBRX | LB PHARMACEUTICALS INC | 1,500,000 | $48.68M | 2.9% | — | — | COM SHS | 50180M108 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 1,415,000 | $38.88M | 2.3% | — | — | COM NEW | 045396207 |
| EDIT | EDITAS MEDICINE INC | 8,889,000 | $28.8M | 1.7% | — | — | COM | 28106W103 |
| KYMR | KYMERA THERAPEUTICS INC | 250,000 | $28.67M | 1.7% | — | — | COM | 501575104 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 6,336,782 | $21.61M | 1.3% | — | — | COM NEW | 46489V302 |
| IPSC | CENTURY THERAPEUTICS INC | 8,695,652 | $21.3M | 1.3% | — | — | COM | 15673T100 |
| ZURA | ZURA BIO LTD | 3,250,000 | $19.18M | 1.1% | — | — | CLASS A ORD SHS | G9TY5A101 |
| AVTX | AVALO THERAPEUTICS INC | 1,018,319 | $18.82M | 1.1% | — | — | COM NEW | 05338F306 |
| IFRX | INFLARX NV | 7,300,000 | $16.35M | 1.0% | — | — | COM | N44821101 |
| ANTX | AN2 THERAPEUTICS INC | 2,933,680 | $14.2M | 0.8% | — | — | COM | 037326105 |
| NUVL | NUVALENT INC | 100,000 | $12.35M | 0.7% | — | — | COM | 670703107 |
| SABS | SAB BIOTHERAPEUTICS INC | 2,870,000 | $11.19M | 0.7% | — | — | COM NEW | 78397T202 |
| IKT | INHIBIKASE THERAPEUTICS INC | 5,397,488 | $10.96M | 0.7% | — | — | COM NEW | 45719W205 |
| RLMD | RELMADA THERAPEUTICS INC | 1,425,000 | $9.861M | 0.6% | — | — | COM | 75955J402 |
| PEPG | PEPGEN INC | 4,475,000 | $8.055M | 0.5% | — | — | COM | 713317105 |
| RACC | RESEARCH ALLIANCE CORP III | 500,000 | $5.35M | 0.3% | — | — | ORD SHS CL A | G75226103 |
| HLXC | HELIX ACQUISITION CORP III | 500,000 | $5.32M | 0.3% | — | — | USD CL A ORD SHS | G4444S107 |
| LONA | LEONABIO INC | 464,398 | $4.268M | 0.3% | — | — | COM | 04746L203 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,788,620 | $630K | 0.0% | — | — | COM | 92840H400 |